© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Switzerland

  • In brief: Yesterday (Wednesday) Pfandbriefzentrale der Schweizerischen Kantonalbanken increased its 3.5% October 2011 bond by Sfr180m, taking the total to Sfr680m.
  • Yesterday (Monday) Pfandbriefbank Schweizerischer Hypothekarinstitute issued a dual tranche deal totalling Sfr757m (Eu489m), showing an immunity to the turmoil elsewhere. However, the issuance included a new short maturity.
  • In brief: Pfandbriefbank schweizerischer Hypothekarinstitute found demand focused at the short end when it came to market with a Sfr340m dual tranche bond this week.
  • In brief: Pfandbriefzentrale der schweizerischen Kantonalbanken priced a dual tranche issue in the domestic Swiss franc market yesterday (Wednesday), raising Sfr550m.
  • Credit Suisse could become the first Swiss bank to issue a standalone covered bond and the first outside the country’s Pfandbrief Act, The Cover understands.
  • In the Swiss franc market Pfandbriefbank Schweizerischer Hypothekarinstitute returned to the bond market after just three weeks, with a Sfr600m dual tranche transaction.
  • An air of despondency settled over the Swiss franc bond market this week, after last week showed promise, with five varied and well executed deals in testing market conditions. However, a domestic issue for Pfandbriefzentrale der Schweizerischen Kantonalbanken lit up the market with the largest deal of the month.
  • Pfandbriefbank Schweizerischer Hypothekarinstitute - the Pfandbrief-issuing bank for the non-cantonal banks in Switzerland - made its largest single visit to the market on Tuesday. The Sfr1.15bn (Eu709m) multi-tranche domestic deal featured a broad range of maturities in an attempt to capture the attention of the full spectrum of investors after the issuer received regulatory approval for it shortest maturity to date.